NCT05230771尚未招募3 期
Clinical Outcome of Palliative Surgery After Translational Therapy Versus Maintenance Chemotherapy for Metastatic Gastric Cancer: a Single Center Randomized Controlled Trial
Fujian Medical University0 个研究点目标入组 120 人开始时间: 2022年4月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
- 主要终点
- 2-year overall survival rate
研究概览
简要总结
This single-center, prospective study was conducted to investigate the efficacy and safety of palliative surgery after translational therapy in the treatment of metastatic gastric cancer. The primary endpoint was 2-year overall survival (OS) rate. Secondary endpoints were median OS, progression-free survival (PFS), 1-year OS, adverse events (AE), severe AE, the quality of life (QOL) and treatment cost.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age from 18 to 75 years
- •Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically
- •CT/MRI, PET-CT, or laparoscopic exploration should be performed before surgery to confirm the diagnosis of distant metastasis
- •Performance status of 0 or 1 on Eastern Cooperative Oncology Group scale (ECOG)
- •Estimated survival time was over 3 months
- •The major organs are functioning normally and meet the following criteria:
- •(1) Blood routine examination should meet the requirements (no blood transfusion within 14 days):
- •WBC≥3×109/L
- •ANC≥1.5×109/L，
- •PLT≥100×109/L； （2）Biochemical tests must meet the following criteria：
- •BIL <1.5×upper limit of normal (ULN)，
- •ALT and AST<2.5ULN，GPT≤1.5×ULN；
- •Cr≤1ULN，Ccr >60ml/min
- •Fertile women must have taken a pregnancy test (serum) within 7 days prior to enrollment with negative results and be willing to use an appropriate method of contraception during the trial period and 8 weeks after the last trial drug; For men, they should be surgically sterilized or agree to use the appropriate method of contraception during the trial period and 8 weeks after the last administration of the trial drug
- •Did not participate in other clinical studies before and during treatment
- •Subjects voluntarily joined the study and signed informed consent with good compliance and follow-up
排除标准
- •History of other malignant disease within past five years
- •History of immunodeficiency, including HIV positive, or other acquired congenital immunodeficiency disease, or a history of organ transplantation and allogeneic bone marrow transplantation
- •Accompanied by serious heart, lung, liver and kidney diseases, neuropsychiatric disorders, jaundice or associated severe infection
- •Women during pregnancy or breast-feeding
- •Subjects had poorly controlled cardiovascular clinical symptoms or diseases, including but not limited to:
- •NYHA class II or more serious heart failure
- •unstable angina pectoris
- •myocardial infarction within 1 year
- •clinically significant ventricular or ventricular arrhythmias that were poorly controlled without or despite clinical intervention
研究组 & 干预措施
Palliative surgery after translational therapy
Experimental
After randomization, patients received palliative surgery after translational therapy
干预措施: Palliative surgery after translational therapy (Combination Product)
Chemotherapy alone
Active Comparator
After randomization, patients received chemotherapy alone
干预措施: Chemotheraoy along (Drug)
结局指标
主要结局
2-year overall survival rate
时间窗: 2 year
Survival rate of patients in the group from the date of enrollment to 2 years after enrollment
次要结局
未报告次要终点
研究者
Chang-Ming Huang, Prof.
chief physician
Fujian Medical University
相似试验
终止
不适用
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver TumorsRhabdoid Tumor of LiverUndifferentiated (Embryonal) Sarcoma of the LiverPediatric Liver CancerLiver TumorsHepatocellular CarcinomaHepatoblastomaNCT04315883Nemours Children's Clinic3
招募中
不适用
Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal StudyBone MetastasesNCT06487013EpiSonica100
招募中
不适用
Silicone Oil Tamponade for Vitrectomy of Hypermyopic Foveoschisis.Hypermyopic FoveoschisisNCT05628909Peking University People's Hospital159
已完成
不适用
Retrospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus ReplacementTalusAnkle ArthropathyNCT05231304Restor3D80
尚未招募
不适用
Study on the Efficacy and Safety of Transarterial Chemoembolization Combined with Targeted Immunotherapy in Patients with Unresectable Hepatocellular CarcinomaUnresectable Liver CancerNCT06715072Yao Xie70